XTRA:EUZMedical Equipment
How Eckert & Ziegler’s Actinium-225 Radio-DARPin Partnership (XTRA:EUZ) Has Changed Its Investment Story
Molecular Partners AG recently announced it has entered into an agreement with Eckert & Ziegler to support development and manufacturing of Radio-DARPin therapeutics, adding Actinium-225 to existing Lead-212–based programs for targeted cancer treatment.
This collaboration broadens Eckert & Ziegler’s isotope platform into advanced Radio-DARPin applications, potentially deepening its role in supplying components for next-generation radiopharmaceuticals.
We’ll now examine how partnering with...